Washington, D.C. – On November 23, 2020, Ryan White Clinics for 340B Access (RWC-340B) and five 340B providers filed a motion in the United States
Earlier this week a third drug manufacturer, Novartis Pharmaceuticals, sent letters to 340B covered entities with contract pharmacy arrangements stating that beginning October 1, 2020,
Today, Astra-Zeneca joined other manufacturers in announcing that it would no longer honor all contract pharmacy arrangements. Astra-Zeneca sent letters to 340B covered entities informing
Following a recent announcement by drug manufacturer Merck, Sanofi recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they participate
Merck Requests That Covered Entities Submit Contract Pharmacy Claims to 340B ESP
Drug manufacturer Merck recently sent letters to 340B covered entities with contract pharmacy
The US Conference on HIV/AIDS (USCHA) announced that this year’s conference will be held virtually on October 19-21, 2020. Registration is free for the first
Federally funded clinics that serve over half a million people living with HIV/AIDS have asked the Trump administration to waive regulations preventing them from using
Powers drafted the attached template COVID-19 Policies and Procedures that incorporate HRSA/OPA’s relaxed guidance to help 340B covered entities address the coronavirus pandemic. We hope
HRSA/OPA Guidance in Response to COVID-19
Late yesterday, HRSA/OPA updated its website to include guidance addressing the COVID-19 pandemic. The guidance states:
Case-by-Case Waivers –
The COVID-19 pandemic has created an increased need for the use of telehealth services. Powers has received several questions from Ryan White clinics about whether
